This inventor holds 1 USPTO granted patent. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Hiroshi Nagasawa: Innovator in Pharmaceutical Chemistry
Introduction
Hiroshi Nagasawa is a notable inventor based in Hatano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thiadiazole derivatives.
Latest Patents
Hiroshi Nagasawa holds a patent for 1,3,4-thiadiazole derivatives, which includes a process for their production. His patent describes new 1,3,4-thiadiazole derivatives of the general formula (I), where R₁ represents a specific group and R₂ can be various functional groups. These derivatives are recognized for their potential use as antiulcer agents. He has 1 patent to his name.
Career Highlights
Nagasawa is associated with Wakamoto Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical applications. His work has contributed to the understanding and utilization of thiadiazole compounds in medicine.
Collaborations
Throughout his career, Hiroshi Nagasawa has collaborated with esteemed colleagues, including Yoshihiro Tsuriya and Toshio Kuroda. These partnerships have fostered innovation and enhanced the impact of their research in the pharmaceutical industry.
Conclusion
Hiroshi Nagasawa's contributions to pharmaceutical chemistry, particularly through his patent on thiadiazole derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile